Sapient Capital LLC Purchases Shares of 19,335 Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Sapient Capital LLC bought a new position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 19,335 shares of the company’s stock, valued at approximately $1,284,000.

Several other institutional investors and hedge funds have also recently modified their holdings of RYAN. Virtu Financial LLC bought a new position in shares of Ryan Specialty in the 4th quarter worth about $283,000. Vanguard Group Inc. boosted its stake in Ryan Specialty by 2.2% during the 4th quarter. Vanguard Group Inc. now owns 9,397,569 shares of the company’s stock valued at $404,283,000 after purchasing an additional 198,945 shares during the last quarter. Kapitalo Investimentos Ltda bought a new stake in shares of Ryan Specialty in the 4th quarter worth $106,000. Renaissance Capital LLC raised its stake in shares of Ryan Specialty by 4.6% in the first quarter. Renaissance Capital LLC now owns 63,364 shares of the company’s stock worth $3,517,000 after purchasing an additional 2,800 shares during the last quarter. Finally, Cooper Financial Group purchased a new stake in shares of Ryan Specialty during the first quarter valued at $261,000. 84.82% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on RYAN shares. Barclays assumed coverage on shares of Ryan Specialty in a report on Wednesday, September 4th. They set an “overweight” rating and a $76.00 price target on the stock. JPMorgan Chase & Co. lifted their price objective on Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a report on Friday, August 2nd. Wells Fargo & Company upped their price objective on Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research report on Thursday, October 10th. Keefe, Bruyette & Woods reiterated an “outperform” rating and set a $62.00 price objective on shares of Ryan Specialty in a research report on Tuesday, July 2nd. Finally, Bank of America upped their price objective on Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $70.33.

Ryan Specialty Stock Up 1.0 %

RYAN opened at $72.48 on Tuesday. The firm has a 50-day simple moving average of $65.82 and a two-hundred day simple moving average of $58.83. Ryan Specialty Holdings, Inc. has a 52 week low of $41.49 and a 52 week high of $72.97. The company has a market capitalization of $18.88 billion, a PE ratio of 136.75, a price-to-earnings-growth ratio of 1.66 and a beta of 0.62. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.81.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Thursday, August 1st. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.56 by $0.02. Ryan Specialty had a net margin of 10.21% and a return on equity of 48.08%. The business had revenue of $695.40 million during the quarter, compared to the consensus estimate of $695.56 million. During the same quarter in the prior year, the firm earned $0.45 EPS. The business’s revenue was up 18.9% on a year-over-year basis. Analysts forecast that Ryan Specialty Holdings, Inc. will post 1.81 earnings per share for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 27th. Investors of record on Tuesday, August 13th were issued a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date was Tuesday, August 13th. Ryan Specialty’s payout ratio is 83.02%.

Insider Activity at Ryan Specialty

In related news, President Timothy William Turner sold 2,000,000 shares of the stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $62.45, for a total value of $124,900,000.00. Following the completion of the transaction, the president now owns 8,095 shares of the company’s stock, valued at approximately $505,532.75. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Nicholas Dominic Cortezi sold 5,375 shares of the firm’s stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $64.73, for a total transaction of $347,923.75. Following the transaction, the director now directly owns 2,685 shares of the company’s stock, valued at approximately $173,800.05. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, President Timothy William Turner sold 2,000,000 shares of the firm’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $62.45, for a total transaction of $124,900,000.00. Following the transaction, the president now directly owns 8,095 shares in the company, valued at approximately $505,532.75. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 2,107,136 shares of company stock valued at $131,860,032. Insiders own 11.10% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.